captopril has been researched along with Ductus Arteriosus, Patent in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elkayam, U; Hurst, A; Shotan, A; Widerhorn, J | 1 |
| Biron, P; Davignon, A; Elie, R; Fournier, A; Fouron, JC; Montigny, M | 1 |
| Boutroy, MJ; Kreft-Jais, C; Plouin, PF; Tchobroutsky, C | 1 |
1 review(s) available for captopril and Ductus Arteriosus, Patent
| Article | Year |
|---|---|
Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use.
Topics: Abnormalities, Drug-Induced; Animals; Blood Pressure; Captopril; Ductus Arteriosus, Patent; Enalapril; Female; Fetal Death; Fetus; Goats; Kidney; Maternal-Fetal Exchange; Oligohydramnios; Pregnancy; Rabbits; Regional Blood Flow; Renal Insufficiency; Risk Factors; Sheep; Uterus; Vascular Resistance | 1994 |
2 other study(ies) available for captopril and Ductus Arteriosus, Patent
| Article | Year |
|---|---|
Captopril in infants for congestive heart failure secondary to a large ventricular left-to-right shunt.
Topics: Captopril; Ductus Arteriosus, Patent; Endocardial Cushion Defects; Heart Failure; Heart Septal Defects; Heart Septal Defects, Ventricular; Hemodynamics; Humans; Infant | 1989 |
Angiotensin-converting enzyme inhibitors during pregnancy: a survey of 22 patients given captopril and nine given enalapril.
Topics: Abortion, Spontaneous; Captopril; Ductus Arteriosus, Patent; Enalapril; Female; Fetal Death; Humans; Hypertension; Infant, Newborn; Infant, Small for Gestational Age; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, Third | 1988 |